+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis



Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis



Journal of Bone and Mineral Research 28(5): 984-991



Bisphosphonates have been shown to reduce mortality in patients with osteoporotic fractures, but the mechanism is unclear. Bisphosphonates have immunomodulatory effects that may influence the development of vascular disease. We sought to determine if bisphosphonate use is associated with a reduced risk of myocardial infarction (MI) in a rheumatoid arthritis (RA) population with high prevalence of bisphosphonate use and vascular disease. Adult patients with RA enrolled in the National Data Bank for Rheumatic Diseases, a longitudinal study of RA patients enrolled continuously from U.S. rheumatology practices between 2003 and 2011, were included in the analysis (n = 19,281). Patients completed questionnaires every 6 months. including questions on medication use, demographic information, clinical information, and health status. MIs were confirmed by a central adjudicator. Among the 5689 patients who were treated with bisphosphonates at some time during the study period, the risk of MI while on bisphosphonate compared to when not on bisphosphonate was 0.56 (95% confidence interval [CI], 0.37-0.86; p < 0.01) after adjustment for multiple confounders. In models including all 19,281 treated and untreated patients, the adjusted risk of first MI was 0.72 (95% CI, 0.54-0.96; p = 0.02) and of all MIs it was 0.72 (95% CI, 0.53-0.97; p = 0.03) in bisphosphonate users compared to nonusers. This finding suggests a potential mechanism for the mortality reduction observed with bisphosphonate medications.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036621597

Download citation: RISBibTeXText

PMID: 23074131

DOI: 10.1002/jbmr.1792


Related references

The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis. Arthritis and Rheumatism 58(9): 2612-2621, 2008

AB0260Flares of Disease Activity as Risk Factor for Myocardial Infarction in Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases 74(Suppl 2): 978.3-978, 2015

Depression increases risk of incident myocardial infarction among Veterans Administration patients with rheumatoid arthritis. General Hospital Psychiatry 31(4): 353-359, 2009

Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. Journal of Internal Medicine 268(6): 578-585, 2011

Biomarker-related risk for myocardial infarction and serious infections in patients with rheumatoid arthritis: a population-based study. Annals of the Rheumatic Diseases 77(3): 386-392, 2017

ACP Journal Club. Patients with rheumatoid arthritis and those with diabetes mellitus had a similar increased risk for myocardial infarction. Annals of Internal Medicine 155(12): Jc6-J11, 2011

Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study. Annals of the Rheumatic Diseases 70(6): 1020-1024, 2011

Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature. Clinical and Experimental Rheumatology 26(4): 673-679, 2008

Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study. Annals of the Rheumatic Diseases 69(11): 1996-2001, 2010

Effect on Risk of Stroke and Acute Myocardial Infarction of Nonselective Nonsteroidal Anti-Inflammatory Drugs in Patients With Rheumatoid Arthritis. American Journal of Cardiology: -, 2018

Rates of myocardial infarction (MI) and cerebrovasculair accident (CVA) are reduced in patients with rheumatoid arthritis (RA) treated with anti-TNF therapy compared to those treated with traditional DMARDs: Results from the BSR biologics register. 2006

FRI0126Who Is at Greater Risk for Myocardial Infarction in Rheumatoid Arthritis?. Annals of the Rheumatic Diseases 75(Suppl 2): 473.3-474, 2016

Rheumatoid arthritis is not associated with myocardial infarction after controlling for other risk factors. Journal of the American College of Cardiology 41(6 Supplement A): 305A, March 19, 2003

Rheumatoid arthritis increased the risk for myocardial infarction in women. Acp Journal Club 139(2): 50-50, 2003

Incidence of myocardial infarction and stroke fatal events and risk of cardiovascular events in rheumatoid arthritis patients. Systematic review of the literature. Annals of the Rheumatic Diseases 66(Suppl. 2): 358-359, 2007